» Articles » PMID: 20518852

A G-CSF Functionalized Scaffold for Stem Cells Seeding: a Differentiating Device for Cardiac Purposes

Overview
Journal J Cell Mol Med
Date 2010 Jun 4
PMID 20518852
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Myocardial infarction and its consequences represent one of the most demanding challenges in cell therapy and regenerative medicine. Transfer of skeletal myoblasts into decompensated hearts has been performed through intramyocardial injection. However, the achievements of both cardiomyocyte differentiation and precise integration of the injected cells into the myocardial wall, in order to augment synchronized contractility and avoid potentially life-threatening alterations in the electrical conduction of the heart, still remain a major target to be pursued. Recently, granulocytes colony-stimulating factor (G-CSF) fuelled the interest of researchers for its direct effect on cardiomyocytes, inhibiting both apoptosis and remodelling in the failing heart and protecting from ventricular arrhythmias through the up-regulation of connexin 43 (Cx43). We propose a tissue engineering approach concerning the fabrication of an electrospun cardiac graft functionalized with G-CSF, in order to provide the correct signalling sequence to orientate myoblast differentiation and exert important systemic and local effects, positively modulating the infarction microenvironment. Poly-(L-lactide) electrospun scaffolds were seeded with C2C12 murine skeletal myoblast for 48 hrs. Biological assays demonstrated the induction of Cx43 expression along with morphostructural changes resulting in cell elongation and appearance of cellular junctions resembling the usual cardiomyocyte arrangement at the ultrastructural level. The possibility of fabricating extracellular matrix-mimicking scaffolds able to promote myoblast pre-commitment towards myocardiocyte lineage and mitigate the hazardous environment of the damaged myocardium represents an interesting strategy in cardiac tissue engineering.

Citing Articles

Promotion of cardiac microtissue assembly within G-CSF-enriched collagen I-cardiogel hybrid hydrogel.

Khodayari H, Khodayari S, Rezaee M, Rezaeiani S, Alipour Choshali M, Erfanian S Regen Biomater. 2024; 11:rbae072.

PMID: 38974665 PMC: 11226883. DOI: 10.1093/rb/rbae072.


The Use of Bioactive Polymers for Intervention and Tissue Engineering: The New Frontier for Cardiovascular Therapy.

Nappi F, Nenna A, Larobina D, Martuscelli G, Avtaar Singh S, Chello M Polymers (Basel). 2021; 13(3).

PMID: 33573282 PMC: 7866823. DOI: 10.3390/polym13030446.


Mechanical Considerations of Electrospun Scaffolds for Myocardial Tissue and Regenerative Engineering.

Nguyen-Truong M, Li Y, Wang Z Bioengineering (Basel). 2020; 7(4).

PMID: 33022929 PMC: 7711753. DOI: 10.3390/bioengineering7040122.


Implantation of a Poly-L-Lactide GCSF-Functionalized Scaffold in a Model of Chronic Myocardial Infarction.

Spadaccio C, Nappi F, De Marco F, Sedati P, Taffon C, Nenna A J Cardiovasc Transl Res. 2017; 10(1):47-65.

PMID: 28116550 PMC: 5323505. DOI: 10.1007/s12265-016-9718-9.


Preliminary In Vivo Evaluation of a Hybrid Armored Vascular Graft Combining Electrospinning and Additive Manufacturing Techniques.

Spadaccio C, Nappi F, De Marco F, Sedati P, Sutherland F, Chello M Drug Target Insights. 2016; 10(Suppl 1):1-7.

PMID: 26949333 PMC: 4772909. DOI: 10.4137/DTI.S35202.


References
1.
Sarkar S, Lee G, Wong J, Desai T . Development and characterization of a porous micro-patterned scaffold for vascular tissue engineering applications. Biomaterials. 2006; 27(27):4775-82. DOI: 10.1016/j.biomaterials.2006.04.038. View

2.
Onodera N, Tamaki T, Okada Y, Akatsuka A, Aoki D . Identification of tissue-specific vasculogenic cells originating from murine uterus. Histochem Cell Biol. 2005; 125(6):625-35. DOI: 10.1007/s00418-005-0113-x. View

3.
Mainil-Varlet P, Rahn B, Gogolewski S . Long-term in vivo degradation and bone reaction to various polylactides. 1. One-year results. Biomaterials. 1997; 18(3):257-66. DOI: 10.1016/s0142-9612(96)00126-3. View

4.
Murry C, Soonpaa M, Reinecke H, Nakajima H, Nakajima H, Rubart M . Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004; 428(6983):664-8. DOI: 10.1038/nature02446. View

5.
Luu Y, Kim K, Hsiao B, Chu B, Hadjiargyrou M . Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J Control Release. 2003; 89(2):341-53. DOI: 10.1016/s0168-3659(03)00097-x. View